×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VOR – vor biopharma inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VOR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/19
09:00 am
vor
Vor Biopharma (VOR) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $30.00 price target on the stock.
Low
Report
Vor Biopharma (VOR) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $30.00 price target on the stock.
2/23
08:00 am
vor
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
High
Report
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
1/23
05:09 am
vor
Vor Biopharma (NASDAQ:VOR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Vor Biopharma (NASDAQ:VOR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
1/9
08:02 am
vor
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $50.00 price target on the stock.
Low
Report
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $50.00 price target on the stock.
1/6
08:00 am
vor
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/23
04:01 pm
vor
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
Medium
Report
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/16
04:15 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
2/17
07:00 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Verve Capital Ltd
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Verve Capital Ltd
2/17
06:22 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Venrock Healthcare Capital Partners III, L.P.
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Venrock Healthcare Capital Partners III, L.P.
2/17
04:14 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: GREAT POINT PARTNERS LLC
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: GREAT POINT PARTNERS LLC
2/17
04:03 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
2/13
07:47 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Qiming Venture Partners VIII-HC, L.P.
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Qiming Venture Partners VIII-HC, L.P.
2/5
01:41 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: FMR LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: